Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: Marc Kahn who wrote (260)	7/21/1998 10:40:00 PM
From: James Strauss	Respond to of 534

Good sleuthing Marc... Expanding Revenues is the first step to profitability... Let's see, there's the U.S. Army, NATO, etc., etc., and Merck, and other pharmaceutical companies, World Health Organization, Public School immunization programs, etc., etc., etc... Jim

To: Marc Kahn who wrote (260)	7/22/1998 7:41:00 AM
From: Dave Ruff	Respond to of 534

The military would really love this product. It is a natural market. If BJCT hasn't pursued this market, they should.

To: Marc Kahn who wrote (260)	7/22/1998 8:11:00 AM
From: geewiz	Read Replies (1) \| Respond to of 534

Marc, Thanks for keeping us posted on news you hear. I do remember Peggy Miller saying last summer that BJCT was making some trials with the military, the old system of multiple injections from one air line was a really bloody affair with everyone's jucies getting spread around. I'm glad to hear that we are getting 1.5 million from MRK, I missed that in the press release. Has this commitment been made for particular vaccines? The ISO cerification must be a done deal for MRK to make such a commitment, was there a press release on this? Anyone have impressions of the new CFO? best, art